MODULATION OF FIBROBLAST ACTIVITY IN HISTIOCYTOSIS-X BY PLATELET-DERIVED GROWTH-FACTOR

被引:12
|
作者
UEBELHOER, M
BEWIG, B
KREIPE, H
NOWAK, D
MAGNUSSEN, H
BARTH, J
机构
[1] CHRISTIAN ALBRECHTS UNIV KIEL,MED KLIN 1,W-2300 KIEL,GERMANY
[2] UNIV KLIN WURZBURG,INST PATHOL,WURZBURG,GERMANY
[3] KRANKENHAUS GROSSHANSDORF,ZENTRUM PNEUMOL & THORAXCHIRURG,W-2070 GROSSHANSDORF,GERMANY
关键词
ALVEOLAR MACROPHAGE; FIBROSIS; HISTIOCYTOSIS X; PLATELET-DERIVED GROWTH FACTOR;
D O I
10.1378/chest.107.3.701
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Platelet-derived growth factor (PDGF) was shown to modulate fibroblast activity in interstitial lung diseases like idiopathic pulmonary fibrosis (IPF). The role of PDGF in fibrosing mechanisms in histiocytosis X is unclear. Eight patients with histiocytosis X, five patients with idiopathic pulmonary fibrosis (IPF), and nine patients with no evidence of interstitial lung disease underwent bronchoalveolar lavage (BAL). The c-sis gene (a proto-oncogen encoding for the B-chain of PDGF) expression was measured by gene hybridization revealing an upregulated c-sis transcript in the group of histiocytosis X and patients, whereas no c-sis expression was detectable in the control group. The alveolar macrophage supernatants from histiocytosis X patients and from the control group were incubated with a human lung fibroblast cell line (WI-38). The mitosis rate was measured by tritiated thymidine incorporation and collagen production was estimated by determining the procollagen III peptide concentration in fibroblast supernatants. Tritiated thymidine uptake was increased 1.6 times in histiocytosis X compared with the control group (p<0.01). Procollagen-III-peptide levels in fibroblast supernatants after incubation with alveolar macrophage supernatants from histiocytosis X were elevated 2.5 times compared with the control group (p<0.01). Prior to incubation with the WI-38 cell line, the cell supernatant then was preincubated with nonpreserved anti-human PDGF (AA- and BB-chain) resulting in an 80% decrease of tritiated thymidine uptake and procollagen-III-peptide production in the group of histiocytosis X patients compared with native supernatants. No significant change in fibroblast activity was seen in the control group. Preincubation with nonpreservated Ki-T2 antibodies as pan T-lymphocyte marker did not show significant differences in both groups excluding unspecific antibody inhibition. These findings suggest increased PDGF production by alveolar macrophages in histiocytosis X patients. The PDGF is in part responsible for increased fibroblast replication and collagen production.
引用
收藏
页码:701 / 705
页数:5
相关论文
共 50 条
  • [31] PLATELET-DERIVED GROWTH-FACTOR AND THE REGULATION OF THE MAMMALIAN FIBROBLAST CELL-CYCLE
    SCHER, CD
    SHEPARD, RC
    ANTONIADES, HN
    STILES, CD
    BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 560 (02) : 217 - 241
  • [32] PLATELET CONTENT AND RELEASE OF PLATELET-DERIVED GROWTH-FACTOR
    VISSINGER, H
    HUSTED, SE
    KRISTENSEN, SD
    NIELSEN, HK
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1157 - 1157
  • [33] THE REGULATION OF EPIDERMAL GROWTH-FACTOR RECEPTORS BY PLATELET-DERIVED GROWTH-FACTOR
    WHARTON, W
    LEOF, E
    PLEDGER, WJ
    OKEEFE, E
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1982, 397 (DEC) : 325 - 326
  • [34] PLATELET-DERIVED GROWTH-FACTOR IS CHEMOTACTIC FOR FIBROBLASTS
    SEPPA, H
    GROTENDORST, G
    SEPPA, S
    SCHIFFMANN, E
    MARTIN, GR
    JOURNAL OF CELL BIOLOGY, 1982, 92 (02): : 584 - 588
  • [35] PURIFICATION OF HUMAN PLATELET-DERIVED GROWTH-FACTOR
    RAINES, EW
    ROSS, R
    METHODS IN ENZYMOLOGY, 1985, 109 : 749 - 773
  • [36] PLATELET-DERIVED GROWTH-FACTOR IN EXPERIMENTAL GLOMERULONEPHRITIS
    ZHANG, G
    ELNAHAS, AM
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (06) : 787 - 795
  • [37] PURIFICATION OF HUMAN PLATELET-DERIVED GROWTH-FACTOR
    MACIAG, T
    TRENDS IN BIOCHEMICAL SCIENCES, 1982, 7 (08) : 270 - 270
  • [38] A RADIORECEPTOR ASSAY FOR PLATELET-DERIVED GROWTH-FACTOR
    SINGH, JP
    METHODS IN ENZYMOLOGY, 1987, 147 : 13 - 22
  • [39] PURIFICATION OF HUMAN PLATELET-DERIVED GROWTH-FACTOR
    HELDIN, CH
    JOHNSSON, A
    EK, B
    WENNERGREN, S
    RONNSTRAND, L
    HAMMACHER, A
    FAULDERS, B
    WASTESON, A
    WESTERMARK, B
    METHODS IN ENZYMOLOGY, 1987, 147 : 3 - 13
  • [40] PLATELETS, PLATELET-DERIVED GROWTH-FACTOR AND ARTERIOSCLEROSIS
    BAUMGARTNER, HR
    HOSANG, M
    EXPERIENTIA, 1988, 44 (02): : 109 - 112